Ligand validation:1Q17

APR: ADENOSINE-5-DIPHOSPHORIBOSE

APR is a Ligand Of Interest in 1Q17 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1Q17_APR_A_1001	74%	3%	0.144	0.974	3.77	2.48	13	17	0	0	100%	1
1Q17_APR_C_1003	73%	3%	0.142	0.97	3.72	2.51	12	15	1	0	100%	1
1Q17_APR_B_1002	70%	3%	0.15	0.967	3.76	2.61	10	15	0	0	100%	1
1SZD_APR_A_1001	92%	3%	0.069	0.959	3.28	2.89	13	16	0	0	100%	1
2FAV_APR_B_477	100%	36%	0.038	0.985	0.92	1.58	2	5	0	1	100%	0.9931
7R3D_APR_BBB_401	98%	66%	0.062	0.983	0.63	0.69	-	1	0	0	100%	1
3RQ6_APR_A_278	97%	38%	0.06	0.976	1.07	1.34	3	4	0	0	100%	1
4EPP_APR_A_501	96%	24%	0.062	0.971	1.76	1.34	8	5	0	1	100%	1
5DUS_APR_A_201	96%	4%	0.07	0.979	4.23	1.58	11	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.